- Division of Basic and Integrative Biological Sciences – DBIB
- Review Branch:
- Oncology – Basic Translational – OBT
- Study Section:
- Tumor Evolution, Heterogeneity and Metastasis – TEHM
Dr. Rolf Jakobi received a Ph. D. from the University of Kaiserslautern, Germany for studies on cloning and characterization of casein kinase 2 (CK-2) at the German Cancer Research Center in Heidelberg. His postdoctoral research and training at the German Cancer Research Center and the University of California, Riverside focused on protein phosphorylation and signal transduction. Dr. Jakobi served as assistant professor of Pharmacology and Toxicology at the Medical College of Wisconsin, Milwaukee and as associate professor of Biochemistry at the Kansas City University of Medicine and Biosciences. Dr. Jakobi’s research focused on the role of p21-activated kinase 2 (PAK-2) in cell growth and cell death and in breast cancer development and progression. In addition, he was involved in studies on the role of cyclooxygenase 2 (COX-2) in colon cancer cell adhesion, motility, and invasion.